Auto-generated from public data. Not the firm's stated position.
Convergence Partners AG appears to focus on early-stage European healthtech and edtech ventures, with particular emphasis on medical device and diagnostic AI applications across neurovascular, cognitive health, and imaging domains. Recent portfolio data suggests a concentration in seed through Series B funding rounds with typical check sizes between €1.5M–€3.0M, positioning the firm as an early-stage specialist in technology-enabled healthcare solutions.
Generated 8 Aug 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
€1.5M – €3M
Website reachable as of Sept 2026. Focus and check size as listed by the firm, not independently verified.
Learn what Convergence Partners AG and similar investors look for:
Edtech pitch guideHealthtech pitch guideTips, programs, and cultural notes
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.